Autoantibodies, human Fcγ receptors, and autoimmunity

References

• Vanderpump MPJ, Turnbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickam Survey. Clin Endocrinol. 1995;43:55–68.
   PubMed Web of Science ®Google Scholar
• Arbuckle MR, Mc Clain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349:1526–1533.
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Tozzoli R, Shoenfeld Y. Are we at a stage to predict autoimmune rheumatic diseases? Arthritis Rheum. 2007;56:1736–1744.
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Blank M, Abu-Shakra M, et al. The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases-2008. Isr Med Assoc J. 2008;10:13–19.
   PubMed Web of Science ®Google Scholar
• Harel M, Shoenfeld Y. Predicting and preventing autoimmunity, myth or reality? Ann N YAcad Sci. 2006;1069:322–345.
   PubMed Web of Science ®Google Scholar
• Bizzaro N. Autoantibodies as predictors of disease: the clinical and experimental evidence. Autoimmun Rev. 2007;6:325–333.
   PubMed Web of Science ®Google Scholar
• Hogarth PM. Fc receptors are major mediators of antibody based inflammation in autoimmunity. Curr Opin Immunol. 2002;14:798–802.
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L. Broken dogma: penetration of autoantibodies into living cells. Immunol Today. 1996;17:163–164.
   PubMedGoogle Scholar
• Alarcón-Segovia D, Llorente L, Ruiz-Arguelles A. Autoantibodies that penetrate into living cells. In: Peter JB, Schoenfeld Y, editors. Autoantibodies. Amsterdam, The Netherlands: Elsevier Science BV; 1996. p. 96–102.
   Google Scholar
• Izuno GT. Observations on the in vivo reaction of antinuclear antibodies with epidermal cells. Br J Dermatol. 1978;98:391–398.
   Web of Science ®Google Scholar
• Alarcon-Segovia D, Ruiz-Arguelles A, Llorente L. Antibody penetration into living cells. II. Anti-ribonucleoprotein IgG penetrates into T gamma lymphocytes causing their deletion and the abrogation of suppressor function. J Immunol. 1979;122:1855–1562.
   PubMed Web of Science ®Google Scholar
• Vlahakos D, Foster MH, Ucci AA, Barrett KJ, Datta SK, Madaio MP Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J Am Soc Nephrol. 1992;2:1345–1354.
   PubMed Web of Science ®Google Scholar
• Bernat RL, Borisy GG, Rothfield NF, Earnshaw WC. Injection of anticentromere antibodies in interphase disrupts events required for chromosome movement at mitosis. J Cell Biol. 1990;111:1519–1533.
   PubMed Web of Science ®Google Scholar
• Sun KH, Tang SJ, Chen CY, et al. Monoclonal ribosomal P autoantibody inhibits the expression and release of IL-12, TNF-alpha and iNOS in activated RAW macrophage cell line. J Autoimmun. 2005;24:135–143.
   Web of Science ®Google Scholar
• Alarcón-Segovia D, Llorente L, Ruiz-Arguelles A, Richaud-Patin Y, Pérez Romano B. Penetration of anti-DNA antibodies into mononuclear cells causes apoptosis. Arthritis Rheum. 1995;38:S179.
   Google Scholar
• Coons AH, Leduc EH, Kaplan MH. Localization of antigen in tissue cells VI: the fate of injecting foreign proteins into the mouse. J Exp Med. 1951;93:173–180.
   PubMed Web of Science ®Google Scholar
• Rosenkranz HS, Erlanger BF, Tanenbaum SW, Beiser SM. Purine- and pyrimidine-specific antibodies: effect on the fertilized sea urchin egg. Science. 1964;145:282–284.
   Web of Science ®Google Scholar
• Reichlin M. Cell injury mediated by autoantibodies to intracellular antigens. Clin Immunol Immunopath. 1995;76:215–219.
   PubMedGoogle Scholar
• Alarcon-Segovia D, Rutz-Arguelles A, Fishbein E. Live human mononuclear cells through Fc receptors. Nature. 1978;271:67–69.
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D, Lorente L. Antibody penetration into living cells IV: different effects of anti-native DNA and anti-ribonucleoprotein IgG on the cell cycle of activated T cells. Clin Exp Immunol. 1983;52:365–371.
   PubMed Web of Science ®Google Scholar
• Andersen I, Anderson P, Elling P, Graudal H. Epidermal nuclear immunoglobulin deposits in some connective tissue diseases: correlations with ENA antibodies. Ann Rheum Dis. 1983;42:163–167.
   Web of Science ®Google Scholar
• Baart de la Faille-Kuyper EH. In vivo nuclear localization of immunoglobulins in clinically normal skin in systemic and procainamide induced lupus erythematosus. Neth J Med. 1974;17:58–65.
   Web of Science ®Google Scholar
• Chen Z, Dobson R, Ainsworth S, Silver R, Maricq H. Epidermal nuclear immunofluorescence: serological correlations supporting an in vivo reaction. Brit J Derm. 1985;112:15–22.
   Web of Science ®Google Scholar
• Izuno GT. Observations on the in vivo reaction of antinuclear antibodies with epidermal cells. Brit J Derm. 1978;98:391–398.
   Web of Science ®Google Scholar
• Gilliam JN. The significance of cutaneous immunoglobulin deposits in lupus erythematosus and NZBxNZW/F1 hybrid mice. J Invest Dermatol. 1975;65:154–161.
   Web of Science ®Google Scholar
• Gilliam JN, Prystowsky SD. Mixed connective tissue disease syndrome. Arch Dermatol 1977;113:583–587.
   Google Scholar
• McCoy RC. Nuclear localization of immunoglobulins in renal biopsies of patients with lupus nephritis. Am J Path. 1972;68:469–478.
   Web of Science ®Google Scholar
• Tan M, Kunkel HG. Immunofluorescent study of the skin lesions in systemic lupus erythematosus. Arthritis Rheum. 1966;9:37–46.
   PubMedGoogle Scholar
• Iwatsuki K, Tagami H, Imaizumi S, Ginoza M, Yamada M. The speckled epidermal nuclear immunofluorescence of mixed connective tissue disease seems to develop an in vitro phenomenon. Brit J Derm. 1982;107:653–657.
   Web of Science ®Google Scholar
• Wells JV Webb J, Van Deventer M, et al. In vivo anti-nuclear antibodies in epithelial biopsies in SLE and other connective tissue diseases. Clin Exp Immunol. 1979;38:424–435.
   PubMed Web of Science ®Google Scholar
• Kramers K, van Bruggen MCJ, Rijke-Schilder TPM, et al. In vivo ANA is a fixation artifact: nucleosome-complexed antinucleosome autoantibodies bind to cell surface and are internalized. J Am Soc Neph. 1996;7:946–954.
   Web of Science ®Google Scholar
• Ruiz-Arguelles A, Perez-Romano B, Llorente L, Alarcon-Segovia D, Castellanos JM. Antibody penetration of anti-DNA antibodies into immature live cells. J Autoimmun. 1998;11:547–556.
   PubMed Web of Science ®Google Scholar
• Alarcon-Segovia D, Llorente L, Ruiz-Arguelles A. The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by disregulation and/or cell damage. J Autoimmun. 1996;9:295–300.
   PubMed Web of Science ®Google Scholar
• Portales-Perez D, Alarcon-Segovia D, Llorente L, et al. Penetrating anti-DNA monoclonal antibodies induce activation of human peripheral blood mononuclear cells. J Autoimmun. 1998;11:563–571.
   PubMed Web of Science ®Google Scholar
• Madaio MP, Yanase K. Cellular penetration and nuclear localization of anti-DNA antibodies: mechanisms, consequences, implications and applications. J Autoimmun. 1998;11:535–538.
   PubMed Web of Science ®Google Scholar
• Reichlin M. Cellular dysfunction induced by penetration of autoantibodies into living cells: cellular damage and dysfunction mediated by antibodies to dsDNA and ribosomal P proteins. J Autoimmun. 1998;11:557–561.
   PubMed Web of Science ®Google Scholar
• Adamus G, Machniki M, Elerding H, Sugden B, Blocker YS, Fox DA. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun. 1998;11:523–533.
   PubMed Web of Science ®Google Scholar
• Wesibart RH, Baldwin R, Huh B, Zack DJ, Nishimura R. Novel protein transfection of primary rat cortical neurons using an antibody that penetrates living cells. J Immunol. 2000;164:6020–6026.
   Web of Science ®Google Scholar
• Tezel G, Wax MB. The mechanism of hsp antibody-mediated apoptosis in retinal neuronal cells. J Neurosci. 2000;20:3552–3562.
   PubMed Web of Science ®Google Scholar
• Ritz MF, Erne B, Ferracin F, Vital A, Vital C, Steck AJ. Anti-MAG IgM penetration into myelinated fibers correlates with the extent of myelin widening. Muscle Nerve. 1999;22:1030–1037.
   PubMed Web of Science ®Google Scholar
• Yu RK, Ariga T. The role of glycosphingolipids in neurological disorders. Mechanism of immune action. Ann NY Acad Sci. 1998;845:285–306.
   PubMed Web of Science ®Google Scholar
• El-Fawal HA, Waterman SJ, DeFeo A, Shamy MY. Neuroimmunotoxicology: humoral assessment of neurotoxicity and autoimmune mechanisms. Environ Health Perspect. 1999;107:767–775.
   PubMed Web of Science ®Google Scholar
• Schulze K, Becker BF, Schultheiss HP. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. Circ Res. 1989;64:179–192.
   PubMed Web of Science ®Google Scholar
• Abedi-Valugerdi M, Hu H, Moller G. Mercury-indued anti-nucleolar autoantibodies can transgress the membrane of living cells in vivo and in vitro. Int Immunol. 1999;11:605–615.
   Web of Science ®Google Scholar
• Schmidt-Acevedo S, Perez-Romano B, Ruiz-Arguelles A. ‘LE Cells’ result from phagocytosis of apoptotic bodies induced by antinuclear antibodies. J Autoimmun. 2000;15:15–20.
   PubMed Web of Science ®Google Scholar
• Tse E, Rabbitts TH. Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy. Proc Nat Acad Sci U S A. 2000;97:12266–12271.
   PubMed Web of Science ®Google Scholar
• Brucato A, Cimaz R, Stramba-Badiale M. Neonatal lupus. Clin Rev Allergy Immunol 2002;23:279–299.
   Web of Science ®Google Scholar
• Sisto M, Lisi S, Castellana D, et al. Autoantibodies from Sjogren’s syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J Autoimmun. 2006;27:38–49.
   PubMed Web of Science ®Google Scholar
• Lisi S, Sisto M, Soleti R, et al. Fcgamma receptors mediate internalization of anti-Ro and anti-La autoantibodies from Sjogren’s syndrome and apoptosis in human salivary gland cell line A-253. J Oral Pathol Med. 2007;36:511–523.
   PubMed Web of Science ®Google Scholar
• Sisto M, Lisi S, Lofrumento D, D’Amore M, Scagliusi P, Mitolo V Autoantibodies from Sjogren’s syndrome trigger apoptosis in salivary gland cell line. Ann N Y Acad Sci. 2007;1108:418–425.
   Web of Science ®Google Scholar
• Lisi S, D’Amore M, Lofrumento D, et al. Modulation of the Fcgamma receptors induced by anti-Ro and anti-La autoantibodies: observations in salivary gland cells. Rheumatol Int. 2008;28:943–948.
   Web of Science ®Google Scholar
• Sisto M, D’Amore M, Scagliusi P, Mitolo V, Lisi S. Selective TNF-alpha gene silencing attenuates apoptosis in human salivary gland epithelial cells. Int JImmunopathol Pharmacol. 2008;21:1045–1047.
   Web of Science ®Google Scholar
• Sisto M, D’Amore M, Lofrumento DD, et al. Fibulin-6 expression and anoikis in human salivary gland epithelial cells: implications in Sjogren’s syndrome. Int Immunol. 2009;21:303–311.
   Web of Science ®Google Scholar
• Lisi S, D’Amore M, Scagliusi P, Mitolo V, Sisto M. Anti-Ro/SSA autoantibody-mediated regulation of extracellular matrix fibulins in human epithelial cells of the salivary gland. Scand J Rheumatol. 2009;38:198–206.
   Web of Science ®Google Scholar
• Sisto M, Lisi S, D’Amore M, Caprio S, Mitolo V, Scagliusi P. Tumor necrosis factor Inhibitors block apoptosis of human epithelial cells of the salivary glands. Ann N YAcad Sci. 2009;1171:407–414.
   Web of Science ®Google Scholar
• Deng SX, Hanson E, Sanz I. In vivo cell penetration and intracellular transport of anti-Sm and anti-La autoantibodies. Int Immunol. 2000;12:415–423.
   PubMed Web of Science ®Google Scholar
• Malmborg AC, Shultz DB, Luton F, et al. Penetration and co-localization in MDCK cell mitochondria of IgA derived from patients with primary biliary cirrhosis. J Autoimmun. 1998;11:573–580.
   PubMed Web of Science ®Google Scholar
• Athanassakis I, Protopapadakis E, Vassiliadis S. Localization of pepstatin’s inhibitory action during Fc-mediated antibody internalization: possible implications for antibody-mediated viral transmission. Cell Immunol. 2000;199:81–88.
   Web of Science ®Google Scholar
• Goldtsein JL, Anderson RGW, Brown MS. Coated pits, coated vesicles and receptor mediated endocytosis. Nature. 1979;279:679–685.
   Web of Science ®Google Scholar
• Okada CY, Rechsteiner M. Introduction of macromolecules into cultured mammalian cells by osmotic lysis of pynocitic vesicles. Cell. 1982;29:33–41.
   PubMed Web of Science ®Google Scholar
• Milligan RI. Protein-protein interactions in the rigor actomyosin complex. Proc Natl Acad Sci U S A. 1996;93:21–26.
   PubMed Web of Science ®Google Scholar
• Golan TD, Grushko G, Shemuel Z, Sigal D, Foltyn V Anti-La+ and anti-Ro+ autoimmune sera favor intranuclear IgG import in cultured epidermal cells. Lupus. 1998;7:121.
   Google Scholar
• Ruiz-Arguelles A, Alarcon-Segovia D. Penetration of autoantibodies into living cells, 2000. Isr Med Assoc J. 2001;3:121–126.
   Web of Science ®Google Scholar
• Kamradt T, Mitchi son NA. Tolerance and autoimmunity N Engl J Med. 2001;344:655–664.
   PubMed Web of Science ®Google Scholar
• Cauza K, Grassauer A, Hinterhuber G, et al. FcgammaRIII expression on cultured human keratinocytes and upregulation by interferon-gamma. J Invest Dermatol. 2002;119:1074–1079.
   Web of Science ®Google Scholar
• Manz R A, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Ann Rev Immunol. 2005;23:367–386.
   PubMed Web of Science ®Google Scholar
• Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol. 1996;8:199–205.
   PubMed Web of Science ®Google Scholar
• Ravetch JV Clynes RA. Divergent roles for Fc receptors and complement in vivo. Annu Rev Immunol. 1998;16:421–432.
   Web of Science ®Google Scholar
• Hulett MD, Hogarth PM. Molecular basis of Fc receptor function. Adv Immunol. 1994;57:1–127.
   PubMed Web of Science ®Google Scholar
• Kimberly RP, Salmon JE, Edberg JC. Receptors for immunoglobulin G: molecular diversity and implications for disease. Arthritis Rheum. 1995;38:306–314.
   PubMedGoogle Scholar
• Daeron M. Fc receptor biology. Annu Rev Immunol. 1997;15:203–234.
   PubMed Web of Science ®Google Scholar
• Anderson CL, Looney RJ. Human leukocyte IgG Fc receptors. Immunol Today. 1986;7:264–266.
   PubMedGoogle Scholar
• Ravetch JV Anderson CL. In: Metzger H, editor. Fc Receptors and the Action of Antibodies. Washington, DC: ASM;1990. p. 211–235.
   Google Scholar
• Gessner JE, Heiken H, Tamm A, Schmidt RE. The IgG Fc receptor family. Ann Hematol. 1998;76:231–248.
   PubMed Web of Science ®Google Scholar
• Sondermann P, Kaiser J, Jacob U. Molecular basis for immune complex recognition: A comparison of Fc-receptor structures. J Mol Biol. 2001;309:737–749.
   PubMed Web of Science ®Google Scholar
• Maxwell KF, Powell MS, Hulett MD. Crystal structure of the human leukocyte Fc receptor, FcgRlla. Nature Struct Biol. 1999;6:437–442.
   PubMedGoogle Scholar
• Sondermann P, Huber R, Jacob U, et al. Crystal structure of the soluble form of the human Fcg-receptor Ilb: a new member of the immunoglobulin superfamily at 1.7 resolution. EMBO J. 1997;18:1095–1103.
   Web of Science ®Google Scholar
• Morton HC, van den Herik-Oudijk IE, Vossebeld P, et al. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association. J Biol Chem. 1995;270:29781–29787.
   PubMed Web of Science ®Google Scholar
• Kew RR, Grimaldi CM, Furie MB, Fleit HB. Human neutrophil FcgRIIIB and formyl peptide receptors are functionally linked during formyl-methionylleucyl-phenylalanine-induced chemotaxis. J Immunol. 1992;149:989–997.
   Web of Science ®Google Scholar
• Takai T. Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol. 2005;25:1–18.
   PubMed Web of Science ®Google Scholar
• Kato K, Sautes-Fridman C, Yamada W, et al. Structural basis of the interaction between IgG and FcyR. J Mol Biol. 2000;295:213–224.
   PubMed Web of Science ®Google Scholar
• Radaev S, Motyka S, Fridman WH, Sautes-Fridman C, Sun PD. The structure of a human type III FcR in complex with Fc. J Biol Chem. 2001;276:16469–16477.
   PubMed Web of Science ®Google Scholar
• Sondermann P, Jacob U, Kutscher C, Frey J. Characterization and crystallization of soluble human FcyRII (CD32) isoforms produced in insect cells. Biochemistry. 1999;29:8469–8477.
   Google Scholar
• ZhangY, Boesen CC, Radaev S, et al. Crystal structure of the extracellular domain of a human FcyRIII. Immunity. 2000;13:387–395.
   PubMed Web of Science ®Google Scholar
• Sondermann P, Huber R, Oosthuizen V, Jacob U. The 3.2-A crystal structure of the human IgG1 Fc fragment-FcyRIII complex. Nature. 2000;406:267–273.
   PubMed Web of Science ®Google Scholar
• Radaev S, Sun P. Recognition of immunoglobulins by FcyR. Mol Immunol. 2002;38:1073–1083.
   PubMed Web of Science ®Google Scholar
• Cowan FM, Broomfield CA, Smith WJ. Sulfur mustard exposure enhances Fc receptor expression on human epidermal keratinocytes in cell culture: implications for toxicity and medical countermeasures. Cell Biol Toxicol. 1998;14:261–266.
   Web of Science ®Google Scholar
• Nitta T, Yagita H, Okumura K, Sato K. Analysis of receptor expression on astrocytic cells. No To Shinkei. 1990;42:945–950.
   Google Scholar
• Dobre MA, Ghetie V. Binding of cytophilic rabbit IgG to homologous hepatocytes. Experientia. 1979;35:763–765.
   Google Scholar
• Andoh T, Kuraishi Y. Direct action of immunoglobulin G on primary sensory neurons through Fc gamma receptor I. FASEB J. 2004;18:182–184.
   Web of Science ®Google Scholar
• Lyden TW, Robinson JM, Tridandapani S, et al. The Fc receptor for IgG expressed in the villus endothelium of human placenta is Fc gamma RIIb2. J Immunol. 2001;166:3882–3889.
   PubMed Web of Science ®Google Scholar
• Antonsson A, Johansson PJ. Binding of human and animal immunoglobulins to the IgG Fc receptor induced by human cytomegalovirus. J Gen Virol. 2001;82:1137–1145.
   Web of Science ®Google Scholar
• Ober RJ, Martinez C, Lai X, Zhou J, Ward ES. Exocytosis of IgG as mediated by the receptor, FcRn: An analysis at the single molecule level. Proc Natl Acad Sci U SA. 2004;101:11076–11081.
   PubMed Web of Science ®Google Scholar
• Ober RJ, Martinez C, Vaccaro C, Zhou J, Ward ES. Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn. J Immunol. 2004;172:2021–2029.
   PubMed Web of Science ®Google Scholar
• Fridman WH, Bonnerot C, Daeron M, Amigorena S, Teillaud JL, Sautes C. Structural bases of Fcy receptor functions. Immun Rev. 1992;125:49–76.
   PubMed Web of Science ®Google Scholar
• Takai T, Li M, Sylvestre D, Clynes R, Ravetch JV FcR y chain deletion results in pleiotrophic effector cell defects. Cell. 1994;76:519–529.
   PubMed Web of Science ®Google Scholar
• Godau J, Heller T, Hawlisch H, et al. C5a initiates the inflammatory cascade in immune complex peritonitis. J Immunol. 2004;173:3437–3445.
   PubMed Web of Science ®Google Scholar
• Shushakova N, Skokowa J, Schulman J, et al. C5a anaphylatoxin is a major regulator of activating versus inhibitory Fcγ Rs in immune complex-induced lung disease. J Clin Invest. 2002;110:1823–1830.
   PubMed Web of Science ®Google Scholar
• Trcka J, Moroi Y, Clynes RA, et al. Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo. Immunity. 2002;16:861–868.
   PubMed Web of Science ®Google Scholar
• Kawanaka N, Yamamura M, Aita T, et al. CD14+,CD16+ blood monocytes and joint inflammation in rheumatoid arthritis. Arthritis Rheum. 2002;46:2578–2586.
   PubMedGoogle Scholar
• Wijngaarden S, van Roon JA, Bijlsma JW, van de Winkel JG, Lafeber FP. Fcgamma receptor expression levels on monocytes are elevated in rheumatoid arthritis patients with high erythrocyte sedimentation rate who do not use anti-rheumatic drugs. Rheumatology (Oxford). 2003;42:681–688.
   PubMed Web of Science ®Google Scholar
• Torsteinsdottir I, Arvidson NG, Hallgren R, Hakansson L. Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol. 1999;115:554–560.
   PubMed Web of Science ®Google Scholar
• Hepburn AL, Mason JC, Davies KA. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 2004;43:547–554.
   PubMed Web of Science ®Google Scholar
• Bunescu A, Seideman P, Lenkei R, Levin K, Egberg N. Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets. J Rheumatol. 2004;31:2347–2355.
   PubMed Web of Science ®Google Scholar
• Broker BM, Edwards JC, Fanger MW, Lydyard PM. The prevalence and distribution of macrophages bearing Fc gamma R I, Fc gamma R II, and Fc gamma R III in synovium. Scand J Rheumatol. 1990;19:123–135.
   PubMed Web of Science ®Google Scholar
• Edwards JC, Blades S, Cambridge G. Restricted expression of Fc gammaRIII (CD16) in synovium and dermis: implications for tissue targeting in rheumatoid arthritis (RA). Clin Exp Immunol. 1997;108:401–406.
   Web of Science ®Google Scholar
• Blom AB, Radstake TR, Holthuysen AE, et al. Increased expression of Fcgamma receptors II and III on macrophages of rheumatoid arthritis patients results in higher production of tumor necrosis factor alpha and matrix metalloproteinase. Arthritis Rheum. 2003;48:1002–1014.
   PubMedGoogle Scholar
• Belostocki K, Pricop L, Redecha PB, et al. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcgamma receptor type II isoforms on neutrophils in patients with rheumatoid arthritis. Arthritis Rheum. 2008;58:384–388.
   Google Scholar
• Wijngaarden S, van de Winkel JG, Bijlsma JW, Lafeber FP, van Roon JA. Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes. Clin Exp Rheum. 2008;26:89–95.
   Web of Science ®Google Scholar
• Wij ngaarden S, van Roon J A, van de Winkel JG, Bijlsma JW, Lafeber FP. Down-regulation of activating Fcgamma receptors on monocytes of patients with rheumatoid arthritis upon methotrexate treatment. Rheumatology (Oxford). 2005;44:729–734.
   Web of Science ®Google Scholar
• Dayyani F, Belge KU, Frankenberger M, Mack M, Berki T, Ziegler-Heitbrock L. Mechanism of glucocorticoidinduced depletion of human CD14+ CD16+ monocytes. J Leuk Biol. 2003;74:33–39.
   PubMed Web of Science ®Google Scholar
• Ravetch JV Perussia B. Alternative membrane forms of Fc gamma RIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med. 1989;170:481–497.
   Web of Science ®Google Scholar
• Hartnell A, Kay AB, Wardlaw AJ. IFN-gamma induces expression of Fc gamma RIII (CD16) on human eosinophils. J Immunol. 1992;148:1471–1478.
   Web of Science ®Google Scholar
• Shen H, Zhang M, Kaita K, Minuk GY, Rempel J, Gong Y. Expression of Fc fragment receptors of immunoglobulin G (Fc gammaRs) in rat hepatic stellate cells. DigDis Sci. 2005;50:181–187.
   PubMed Web of Science ®Google Scholar
• Magnusson SE, Engström M, Jacob U, Ulfgren AK, Kleinau S. High synovial expression of the inhibitory FcgammaRIIb in rheumatoid arthritis. Arthritis Res Ther. 2007;9:R51.
   Web of Science ®Google Scholar
• Baugh JA, Bucala R. Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr Opin Drug Discov Devel. 2001;4:635–650.
   PubMedGoogle Scholar
• Sandborn WJ. Strategies for targeting tumour necrosis factor in IBD. Best Pract Res Clin Gastroenterol. 2003;17:105–117.
   PubMed Web of Science ®Google Scholar
• Reimold AM. TNF alpha as therapeutic target: new drugs, more applications. Curr Drug Targets Inflamm Allergy. 2002;1:377–392.
   PubMedGoogle Scholar
• Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10:411–452.
   PubMed Web of Science ®Google Scholar
• Jespers L, Roberts A, Mahler S, et al. Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Biotechnology. 1994;12:899–903.
   PubMed Web of Science ®Google Scholar
• Salfeld J, Kaymakgalan Z, Tracey D, et al. Generation of fully human anti-TNF antibody D2E7. Arthritis Rheum. 1998;41:S57.
   Web of Science ®Google Scholar
• Cassard L, Cohen-Solal JF, Galinha A, et al. Modulation of tumor growth by inhibitory Fcy receptor expressed by human melanoma cells. J Clin Invest. 2002;110:1549–1557.
   PubMed Web of Science ®Google Scholar
• Wijngaarden S, van de Winkel JG, Bijlsma JW, Lafeber FP, van Roon JA. Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes. Clin Exp Rheumatol. 2008;26:89–95.
   Web of Science ®Google Scholar
• Nakamura A, Akiyama K, Takai T. Fc receptor targeting in the treatment of allergy, autoimmune diseases and cancer. Expert Opin Ther Targets. 2005;9:169–190.
   PubMed Web of Science ®Google Scholar
• Pietersz GA, Mottram PL, van de Velde NC, et al. Inhibition of destruc – tive autoimmune arthritis in Fc gamma RIIa transgenic mice by small chemical entities. Immunol Cell Biol. 2009;87:3–12.
   Web of Science ®Google Scholar